[1]
C. Hopirtean and V. Nagy, “Optimizing the use of anti VEGF targeted therapies in patients with metastatic colorectal cancer: review of literature”, Medicine and Pharmacy Reports, vol. 91, no. 1, pp. 12-17, Jan. 2018.